Stockreport

Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments [Yahoo! Finance]

Y-mAbs Therapeutics, Inc.  (YMAB) 
Last y-mabs therapeutics, inc. earnings: 11/13 04:01 pm Check Earnings Report
PDF Reported Worldwide DANYELZA net product revenues of $19.4 million for the first quarter of 2024, representing a 4% YoY decrease due to international volumes Cash and [Read more]